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Abstract 
Developing generic strategies for building adaptable or multi-functional bio-platforms is 
challenging, in particular because protein immobilization onto surfaces often causes loss of protein 
function and multi-functionality usually necessitates specific combinations of heterogeneous 
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elements. Here we introduce a generic, modular bio-platform construction strategy that uses cage-
like supramolecular multi-enzyme complexes as highly adaptable building blocks immobilized 
directly and non-covalently on graphene. Thermoplasma acidophilum dihydrolipoyl 
acyltransferase (E2) supramolecular complexes organize as a monolayer or can be controllably 
transferred onto graphene, preserving their supramolecular form with specific molecular 
recognition capability and capacity for engineering multi-functionality. This E2-graphene platform 
can bind enzymes (here, E1, E2’s physiological partner) without loss of enzyme function; in this 
test case, E1 catalytic activity was detected on E2-graphene over six orders of magnitude in 
substrate concentration. The E2-graphene platform can be multiplexed via patterned co-transfer of 
differently modified E2 complexes. As the E2 complexes are robust and highly customizable, E2-
graphene is a platform onto which multiple functionalities can be built. 
1. Introduction 
Flexible and unified strategies for tailoring a variety of functions on a single bio-platform are 
highly desirable. Multi-functionality is usually built in by non-generic combination of 
heterogeneous elements.1 One generic approach used non-covalent functionalization of sensing 
platforms,2,3 nanostructures4 and nanomaterials4,5 with peptides selected from combinatorial 
libraries. Supramolecular bio-complexes, however, could provide multi-functionality with 
adaptable biorecognition in fewer steps. Biomolecular nanoscale architectures on surfaces have 
been exploited or created for biosensing, biocatalysis, biofuel cells and biobatteries6-9. These have 
often used a synthetic or natural polymer scaffold,10,11 including synthetic protein scaffolds12 or 
inorganic nanoparticles13 to allow immobilization or embedding of biomacromolecules or 
organelles with functional retention or enhancement.  
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Since its outstanding sensitivity to chemical functionalization was demonstrated,14 graphene has 
been investigated for sensing chemical and biological analytes.15-17 As for carbon nanotubes, non-
covalent functionalization allows preservation of graphene’s electronic properties18 and is thus 
beneficial for sensor design. Numerous approaches have been used to so functionalize graphene. 
Peptides screened for graphene binding19,20  were linked to anti-microbial peptides that bind 
bacterial pathogens,21 or used to detect streptavidin against a background of bovine serum 
albumin.22 Tripodal NHS-esters were designed to -stack on graphene and create protein 
conformation-preserving interfaces.23,24 Photosystem I (PSI), a very large, polar supercomplex, 
was immobilized on a polycyclic aromatic compound-modified graphene interface;25 controlling 
PSI orientation relative to the functionalized graphene surface allowed better electrochemical 
communication with the electrode. Studies of non-covalent graphene functionalization with DNA 
include DNA aptamer-based sensors.26 Other examples involve host–guest supramolecular 
interactions27,28 and acetylcholinesterase covalently grafted to polymer brushes.29 Direct graphene 
functionalization with protein is less common, but one notable example is the hydrophobins, 
amphipathic fungal proteins that form a monolayer on graphene.30 
Here we show that the versatile and robust central scaffold of naturally occurring supramolecular 
multi-enzyme 2-oxoacid dehydrogenase complexes (OADHCs)31,32 can be immobilized directly 
on graphene to create a versatile platform for sensing or other applications.  OADHCs are 
composed of multiple copies of three enzymes: E1 (2-oxoacid decarboxylase), E2 (dihydrolipoyl 
acyltransferase) and E3 (dihydrolipoamide dehydrogenase). An E2 monomer comprises N-
terminal lipoyl domain (E2lipD), peripheral subunit binding domain (PSBD) and catalytic 
acyltransferase domain (Figure 1).31 Multiple copies of the E2 acyltransferase domain assemble to 
form the core scaffold of OADHCs. E1 and E3 assemble around this E2 core scaffold via non-
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covalent protein-protein interactions; E1 and E3 bind specifically and mutually exclusively to the 
PSBD of E233,34 (Figure 1). The E2 core scaffold is a naturally occurring cage-like protein 
supramolecular complex composed of E2 trimers at each vertex of a polyhedron to give a total of 
24, 42 or 60 E2 monomers, depending on the particular complex and source organism.35,36  
 
We use the E2 protein supramolecular complex from Thermoplasma acidophilum (T. 
acidophilum), a thermophilic archaeon, to bio-functionalize graphene directly, without a  
stacking agent or other chemical linker. The strength of, and rationale for, this approach arise from 
the following characteristics of E2 supramolecular complexes: E2 complexes assemble 
reproducibly from E2 monomers;32,35 E2 complexes have excellent production and handling 
properties e.g. T. acidophilum E2 complexes are stable up to 60 ºC;37 E2 complex symmetry means 
that controlling orientation on graphene is much less critical than it would be for most proteins; 
E2 complexes have both exterior and interior surfaces, so can be used as scaffolds,38,39 
cages/capsules40,41 or reaction vessels,42 or a combination of these;43 by fusing the catalytic 
acyltransferase domain (Figure 1) with (poly)peptides other than E2lipD and PSBD, an E2 
complex can be assembled from a mixture of different monomers;44 the functionality of the interior 
and exterior surfaces can be post-translationally manipulated,  for example by introducing non-
native surface cysteines for functionalization45 or by exploiting sortase A to decorate the E2 
complex exterior with multiple functional entities;38,39 and E2 complexes can be converted to 
molecular switches via site directed amino acid changes that make complex assembly responsive 
to external conditions such as pH.46,47 E2 complexes are therefore highly customizable and can be 
rendered multi-functional. These properties combined make E2 complexes suitable vehicles for 
biotechnological, therapeutic, and diagnostic applications. If E2 complex functionality can be 
 5 
preserved while interfaced with the solid state, moreover, as we demonstrate here, E2 complexes 
can become a generic template for incorporation into bio-platforms of multiple recognition/binding 
or catalytic elements, for example, promising single-platform multi-functionality. 
 
Here we have created a modular E2 complex-functionalized graphene platform, and 
demonstrated its viability for sensing through partner enzyme (E1) binding and activity 
measurement; E1 alone did not show any activity on bare graphene. This is also the first structural 
study of E2 complexes interfaced with the solid state: combined information from atomic force 
and transmission electronic microscopies (AFM and TEM) shows that E2 complexes retain a 
supramolecular structure upon direct adsorption onto graphenic surfaces. Graphene obtained by 
chemical vapor deposition (CVD),48 a thin film material of interest for many practical electronic48 
and bioelectronics devices,17,21,49 emerges as a suitable solid state interface for E2, offering 
assembly opportunities and facilitating electron transfer. Finally, we have also shown transfer of 
different variants of E2 complexes onto graphene as a first step towards creation of multiplexed, 
multi-functional devices. 
 
2. Results and Discussion 
2.1. E2 complex synthesis and characteristics 
Full length T. acidophilum E2, including catalytic and peripheral domains (Figure 1), was 
obtained in its monomeric form as previously described (see Supporting Information – SI – Figure 
S1).37 T. acidophilum E2 complex assembly is temperature driven.37 Assembly at 55 °C resulted 
in predominantly 60-mer E2 complexes (see below and SI, Figure S3): 60 copies of E2 
acyltransferase domain self-assemble to form the OADHC core, each E2 also providing an E2lipD 
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and a PSBD which are arranged around the core. E2 trimers assemble in the corners of a 
dodecahedron giving icosahedral symmetry35 (Figure 1). Once assembled, the E2 supramolecular 
complexes are stable for at least a week if stored at 4 °C in PBS, as is purified E2 partner enzyme 
E1. 
 
Figure 1. Schematic structure of the catalytic core of a 60-mer E2 complex. The catalytic domains 
of E2 monomers can assemble into dodecahedral (60-mer)31 or cubic (24-mer; not shown here)31 
or oblate spheroid (42-mer; not shown here)36 complexes. In an E2 60-mer, trimers of the E2 
catalytic domain occupy each corner of the dodecahedron (E2 monomers making up one trimer 
are shown in green, red and blue). The peripheral subunit binding domain (PSBD) and E2 lipoyl 
domain (E2lipD) of each E2 monomer extend from the catalytic core via unstructured linkers 
(linkers not shown to scale). A molecule of E1 (yellow), the natural binding partner of E2, can 
bind to each PSBD on the E2 complex (for simplicity, only one E1 molecule is shown).  
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2.2. Interfacing E2 with graphene: structural characterization 
When building the platform comprising E2 complexes immobilized on graphene, henceforth 
termed E2-graphene, we were interested in characteristics that can affect platform performance. Is 
E2 complex supramolecular structure preserved while interacting with graphene? What is the 
nature and strength of this interaction? Do E2 complexes create monolayers? What is the protein 
uptake on graphene, and can this be controlled? 
 
To address these questions, we compared adsorption, assembly on surfaces and structural 
changes of E2 complexes interfaced with several graphene-based substrates: (i) CVD graphene; 
(ii) atomically flat, basal plane highly oriented pyrolytic graphite (HOPG); and (iii) single- or few-
layer graphene (FLG) flakes obtained through mechanical exfoliation of graphite50 (of, typically, 
tens of microns in lateral size), with smoothness intermediate between HOPG and CVD graphene. 
Both CVD graphene and FLG flakes were supported on SiO2/Si substrates. In order to reveal 
adsorption/assembly characteristics and high resolution morphology of immobilized E2, we used 
atomic force microscopy (AFM) operated in tapping mode at low forces51,52 (Experimental Section 
and SI), in air and liquid, and in both imaging and spectroscopic modes. AFM was supplemented 
by TEM of E2 complexes supported by CVD graphene membranes, with corroboration from 
images of individual complexes in frozen solution by cryo-EM (SI, Figure S3).  
 
Of primary interest for applications was large area, high throughput CVD-grown graphene: it is 
suitable for cost-effective sensor production (including flexible substrates),48,49 can be transferred 
cleanly onto insulating surfaces, and offers adequate performance as an electrode relative to 
carbon-based electrodes.53 In terms of suitability for E2 complex solid state interfacing, we 
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expected CVD graphene to resemble basal plane HOPG, a substrate routinely used for molecular 
self-assembly; HOPG, in contrast to CVD graphene, is a poor electrode.54 
 
E2 complex uptake on graphenic surfaces via direct, non-covalent attachment 
For structural investigation, E2 complexes were transferred onto the aforementioned graphene 
surfaces using filter paper drying: E2-incubated surfaces were dried by turning the sample upside 
down with only the water meniscus allowed to come into contact with filter paper. This resulted 
in broadly reproducible percentage coverage with protein uptake controlled by varying 
concentration/adsorption time, and isolated complexes at low coverage (Figure 2) which could be 
reliably investigated by AFM in air. Alternatively, samples were not allowed to dry, surface 
attachment taking place directly from liquid. This complementary air/liquid approach for high 
resolution AFM structural investigations was used due to insufficient immobilization of individual 
E2 complexes for AFM scanning in liquid (see SI). 
 
After transfer of E2 complexes by filter paper drying, hydrophobic HOPG and FLG flake 
surfaces became highly hydrophilic. On HOPG (Figure 2(a)) and CVD graphene (Figure 2(b)), 
individual complexes could be identified as dome-like structures, with internal details visible in 
higher resolution images (Figure 3). We show only one example of sub-monolayer coverage on 
FLG flakes due to the larger variability in percentage coverage (Figure 2(c)); some coalescence of 
the E2 complexes occurred, which we attribute to confinement effects caused by the microscopic 
boundaries of the flake. Uptake on CVD graphene seemed slightly higher than on HOPG and FLG, 
possibly related to the presence at low density of hydrophilic groups on CVD graphene (SI, Figure 
S5). The resulting E2 complex monolayer had a higher degree of disorder than on HOPG or FLGs, 
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attributed to CVD graphene being slightly rougher than exfoliated FLGs (SI, Figure S6) due to 
different processing methods. Nevertheless, images at varying degrees of coverage indicate that 
stacking of E2 complexes does not occur; this is advantageous as such stacking could slow electron 
transfer to graphene during electrochemical sensing. Initially, a detailed comparison of 
supramolecular E2 with monomeric E2 on graphene was also planned. In contrast to 
supramolecular E2 complexes, however, E2 monomers clustered together and possibly stacked on 
graphenic surfaces, creating an inhomogeneous protein layer with highly uneven height profile 
and morphology (Figure S7). This showed that, in contrast to E2 complexes, there is less control 
over E2 monomer orientation, and creation of monolayers or layers with controlled thickness from 
them.  
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Figure 2. AFM topographic images of representative E2 complex coverage from filter paper 
drying on various graphenic surfaces. Row (a): HOPG. Row (b): CVD graphene. Row (c): FLG 
flake. Under each panel, the corresponding incubation time, t, is indicated. Individual complexes 
are clearly seen at sub-monolayer coverage on all surfaces. In each row, panel 5 shows details of 
framed regions from corresponding main images, with focus on the height profile of complexes 
on each of the three graphenic surfaces. Row (c) shows the topography of an FLG flake before and 
after E2 incubation, panels 1 and 2, respectively; panels 3 and 4 are topography and phase (for 
enhanced visibility of E2 complexes) images, of framed region from panel 2; panel 5 also shows 
the thickness of the bare graphene flake (line profile A-A).  
 
Data acquired in liquid on samples that were never dried (Figure 3(c) and SI, Figure S9) confirm 
that no stacking of E2 complexes occurs by direct attachment, ensuring monolayer formation at 
complete coverage. E2 complexes adsorb onto graphenic surfaces directly from solution, 
pointing to interactions such as van der Waals and - interactions (as opposed to the mere 
drying process) as the trigger for their attachment. The process leads to monolayers (Figure 3(c), 
panel 2), showing that the complex-complex interaction while surrounded by buffer is too weak 
to cause stacking. The E2-graphene interaction while surrounded by liquid is relatively weak, as 
expected from non-specific, non-covalent interaction, such that the tapping AFM tip can swipe 
clean the surface at moderate scanning speeds (a few Hz/scanline) (SI, Figure S9). Graphene-
supported E2 complexes are stable when immersed in PBS and two-fold diluted PBS, while they 
disintegrate if stored in pure water.  
 
High resolution features of graphene-supported E2 complexes 
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High resolution imaging can inform about the extent to which E2 supramolecular structure is 
retained after attachment to graphene. TEM of E2, in dried state on CVD graphene membranes, 
and stained for contrast (Figure 3(a)), revealed polyhedral, cage-like, graphene-bound E2 
complexes that are ~17 0.8 nm across (less than ~22 nm as in structural models of Bacillus 
stearothermophilus pyruvate dehydrogenase, a 60-mer E2 complex,32 possibly due to 
dehydration)55, and somewhat poly-disperse overall. We observed two high symmetry orientations 
with five-fold and three-fold projections respectively (Figure 3(a) insets), which correlate well 
with supporting cryo-EM images of T. acidophilum 60-mer E2 (SI, Figure S3). High resolution 
AFM of graphene-supported individual E2 complexes and of assembled monolayers, in air (Figure 
3(b)) and liquid (Figure 3(c)), revealed intra-cage details of individual E2 complexes. All these 
images show units with a “spokes-on-wheel” aspect; lobe-like components are arranged with five-
fold symmetry around a central cavity (e.g. Figure 3(b)), consistent with the cryo-EM pentagon 
projection of the polyhedral cage (Figure S3). We assign the lobe-like units to the trimer assembly 
in the corners of the E2 polyhedron (Figure 1). The combined evidence points to 60-mer E2 as the 
predominant assembly in our samples. Figure 3(c), panel 2 shows the CVD graphene-bound E2 
complexes while in buffer solution assembled in a compact, full layer: E2 complexes appear to 
preferentially show the “spokes-on-wheel” face, consistent with their pentagonal sides facing the 
viewer and, consequently, also the graphene substrate. A full monolayer of E2 complexes on 
graphene amounts to 1400 ng cm-2 approximately (see SI). We also note that in all AFM images 
(Figures 2 and 3), E2 complexes appear as near-identical units on a given surface. This would be 
difficult to maintain were the E2 complexes to undergo major loss of structure and indicates that 
the E2 complexes are robust to interfacing with graphene.  
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Figure 3. Structural details from TEM and high resolution AFM of E2 complexes adsorbed on 
CVD graphene. (a) TEM (at 100 keV) of dry, uranyl acetate-stained E2 complexes reveals the 
polyhedral structure of the E2 cage, with both five- and three-fold projections (see insets); to be 
compared with cryo-EM, Figure S3. (b) AFM phase image obtained in tapping mode in air, in a 
regime of attractive, non-compressive dynamic forces51,52 on a partial E2 layer: within, five-lobe 
units (examples circled), consistent with the five-fold projection of the E2 complex polyhedral 
cage seen in TEM and cryo-EM. (c) Topographic images, tapping mode in liquid of individual 
complexes (c, panel 1), and complete self-assembled monolayers (c, panel 2). No protein fixation 
protocol was used (see SI). 
 
E2 complex structural deformation upon interaction with hydrophobic and hydrophilic 
surfaces 
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The apparent, measured height after drying of E2 complexes (as obtained from tapping mode 
AFM in air operated in a regime of no compressive forces, see Experimental Section) on all 
graphene-based surfaces is 8-9 nm (Figure 2); corrections based on analysis of AFM spectroscopic 
curves led to real heights ~ 10-11 nm (SI, Figure S10), i.e. lower than the diameter of ~17 0.8 
nm that we observed in TEM. This demonstrates a significant compression of the hollow E2 
complexes after drying on graphene-based surfaces. However, similar E2 complex heights were 
also obtained on HOPG functionalized with 1-pyrene butanoic acid succinimidyl ester (intended 
to prevent protein collapse)56 which -stacks on graphite and links covalently to protein surface 
NH2 groups (SI, Figure S11), showing that such a linker strategy may not offer advantages over 
direct functionalization of graphene with E2 complexes. To put the E2 deformation on the 
hydrophobic graphene surfaces into a wider context, we compared it with the height of E2 
complexes (adsorbed using same protocol) after drying on hydrophilic surfaces, such as SiO2, a 
surface with a roughness around ~ 0.5 nm rms, and atomically flat sapphire (keeping in mind that 
the E2 complex surface offers both hydrophilic and hydrophobic sites for interaction, without any 
large clusters of positively or negatively charged side chains; SI, Figure S2). E2 complex height 
after drying on hydrophilic surfaces (SI, Figure S11) was ~4 nm, compared to 10-11 nm on 
graphenic ones. This is compatible with significantly stronger E2 complex interaction with 
hydrophilic surfaces, suggesting that graphene alters E2 complex conformation less than 
hydrophilic surfaces. 
 
We also induced drying-mediated self-assembly of E2 complexes (by allowing a drop of liquid 
to dry in static air in a glovebox),57 where not just mere adsorption from liquid onto surface takes 
place, but dynamic forces induced by the receding liquid front during drying drive the complexes 
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to move across the surface. E2 complexes organize on graphenic surfaces (CVD, mechanically 
exfoliated graphene, and HOPG) in network-, cellular-, and labyrinth-type patterns58 that strikingly 
resemble those induced in colloidal complexes57 (SI, Figure S8).  Such patterns can form only if 
the E2 complexes have sufficient surface mobility,57,59 proving that the graphenic surface-E2 
complex interaction at the liquid-solid interface is weak. A weak interaction favors preservation 
of E2 complex supramolecular structure. In contrast, in similar experiments with a range of 
hydrophilic substrates (such as atomically flat sapphire and SiO2), E2 complexes lacked mobility 
and did not form such patterns, remaining isolated (SI, Figure S8 (a)). This indicates that at the 
liquid-solid interface, E2-hydrophilic surface interaction is much stronger than E2-hydrophobic 
(graphenic) surface interaction, correlating with E2 complex height collapse while dry on 
hydrophilic surfaces. 
 
Overall, both TEM and AFM evidence in liquid and in air, including high resolution features 
and surface assembly characteristics, corroborates that E2 largely retains its supramolecular 
structure on graphene; this is an important property for future utility of this first iteration of the 
E2-graphene bio-platform. Molecular dynamics (MD) simulations in explicit solvent indicate that 
like the E2 complex, immunoglobulin G (IgG) and bovine serum albumin retain their structures 
upon adsorption on graphene.60,61 In the IgG case, the simulation results were supported by AFM 
images.60 MD simulations suggest that IgG-graphene adsorption is dominated by van der Waals 
forces, and this is thought to be the case for graphene adsorption of large proteins more generally.60 
While van der Waals forces may also be prominent in E2 complex adsorption on graphene, 
contributions from other interactions such as π-π stacking cannot be ruled out. Analysis of the 3D 
structures of T. acidophilum E2lipD62  and Geobacillus stearothermophilus PSBD-E1 complex33 
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suggests, for example, that in T. acidophilum E2 the side chains of Tyr2 within E2lipD and Tyr148 
within PSBD are sufficiently exposed to be capable of interacting with graphene without 
substantial disruption of the E2lipD or PSBD structures. A combination of such π-π interactions 
with van der Waals forces would permit adsorption of E2 complexes with retention of 
supramolecular structure. If the E2-graphene interaction involves solely or mainly the linkers and 
peripheral domains, E2lipD and PSBD (Figure 1), on one side of the complex then the E2 catalytic 
domain core assembly is even less likely to be disrupted. Additionally, even if the peripheral 
domains contacting graphene were partially or fully unfolded, the core catalytic domain scaffold 
and peripheral domains exposed to solvent would be likely to remain folded. Evidently the 
interaction permits E2 complex mobility over the graphene surface, compatible with our 
observations that E2 complexes form network-, cellular- and labyrinth-type patterns on graphenic 
surfaces and that an AFM tip at moderate scanning speeds can swipe clean E2-graphene. The 
apparent height reduction of E2 complexes on graphene, as indicated by the difference between a 
diameter of about 17 nm measured by TEM and a height of 10-11 nm measured by AFM, may 
reflect crumpling of the inter-domain linkers (Figure 1) on the face of the complex that interacts 
with graphene. Due to the symmetry of the E2 complex, the nature of the E2-graphene interaction 
is probably largely uniform across the E2 complex population, in line with the consistent aspect 
of E2 complexes presented in the high resolution AFM images (Figure 3), and explaining the 
relatively homogeneous monolayer coverage of graphene (Figure 2). On the hydrophilic SiO2 and 
sapphire surfaces, the severe height reduction to ~4 nm indicates that the E2 complex experiences 
substantial disruption, potentially including at least partial disassembly of the core catalytic 
domain scaffold.  
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2.3. E2-graphene as a biosensing platform 
For sensing it is crucial to demonstrate that E2-graphene can bind a target molecule specifically 
without activity loss. We therefore tested E1, one of E2’s physiological partner enzymes, in 
conjunction with E2-graphene. Before assays, E1 was incubated with its natural cofactor, thiamine 
pyrophosphate (TPP).  TPP facilitates the carbon-carbon bond cleavage involved in E1-catalysed 
oxidative decarboxylation, in this case the carbon-carbon bond adjacent to the carbonyl group of 
the E1 substrate 3-methyl-2-oxopentanoate.  
 
E1 binding to E2-graphene was demonstrated through a combination of AFM imaging (Figure 
4(a)) and field effect transistor (FET) transconductance measurements (Figure 4(b), and SI). Figure 
4(a) compares the morphology of E2-graphene before (panel 1) and after (panel 2) early stage 
incubation with E1 (i.e. 10 minutes incubation, compared to 40 minutes incubation used in 
electrochemical assays); this shorter incubation allowed recognition of the targeted area, before 
E1 coverage completely obscures the E2 layer. The image after E1 incubation (panel 2) appears 
fuzzier and with increased coverage, while framed regions highlight differences due to bound E1 
in easily recognizable areas. By comparing the height distributions derived from the images in 
panels 1 and 2 (see panel 3), after E1 incubation there is clear diminution of the counts in the lower 
region (which we attribute to the AFM tip probing regions between neighboring E2 complexes); 
instead, the distribution shifts towards greater height, directly demonstrating E1 presence on E2-
graphene. We also followed how FET transconductance against electrochemical gate voltage 
changes with E1 binding until saturation is achieved. E2-graphene was successively incubated 
with increasingly concentrated E1 solutions, each incubation being followed by a 
transconductance measurement (see Experimental Section). The transconductance curves shifted 
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neutrality point towards higher gate voltages and broadened considerably with E1 accumulation, 
until saturation (Figure 4(b)). This is consistent with a decrease in gating efficiency of the 
electrolyte due to changes in dielectric constant of the electrical double layer at the solid-liquid 
interface rather than a direct charge transfer effect due to E1; similar behavior was observed by 
Chen et al.63 This conclusion is supported by opposite and different tendencies obtained by testing 
for both PBS effects and E2 binding, respectively, on the graphene transconductance vs. gate 
voltage curves (see further discussion in SI and Figures S12 and S13).  
 
We then tested the electrochemical activity of bound E1 by using E2-graphene as an electrode 
(see Experimental Section). We used cyclic voltammetry (CV) and chronoamperometry to monitor 
E1-catalysed decarboxylation of 3-methyl-2-oxopentanoate to 3-methyl-4-hydroxy-butyl, 
employing 2,6-dichlorophenol indophenol (DCPIP) as artificial electron acceptor (mediator) to 
complete the redox cycle (Figure 4(c)). The subsequent steps in the physiological reaction 
sequence of a complete E1-E2-E3-lipoate ligase system would be lipoylation of TPP-E1-3-methyl-
4-hydroxy-butyl (where TPP is E1’s coenzyme) by lipoamide-E2 followed by release from TPP 
of 3-methyl-butanal-dihydrolipoamide-E2 and then reaction with coenzyme A (CoA) to form 3-
methyl-butyl-CoA. Here, however, the E1 reaction is decoupled: there is neither lipoic acid nor 
lipoate ligase in the reaction mixture, both of which are required to form lipoamide-E2, and so E1-
catalyzed decarboxylation of 3-methyl-2-oxopentanoate is the only enzymatic reaction taking 
place, with DCPIP as final electron acceptor.  
 
Both bare graphene and E2-graphene electrodes are low noise, with featureless and low 
capacitive backgrounds in the absence of DCPIP (Figure 4(d)); this promotes high signal-to-noise 
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detection. When DCPIP mediator was added, the bare graphene electrode produced a 
voltammogram reflecting the redox process of DCPIP (Figure 4(d) and SI, Figure S14 (a)-(c)).   
Further, when E1 substrate, 3-methyl-2-oxopentanoate, was added to an electrochemical cell 
containing E1-E2-graphene electrode and DCPIP, the DCPIP-mediated redox process intensified 
with increasing E1 substrate concentration, clearly demonstrating bioelectrocatalysis (Figure 4(d)). 
Figure S14 shows a full set of voltammograms, spanning a large substrate concentration range: 
sensitivity is higher at lower E1 substrate concentrations, between 10-9 M and 10-6 M, followed by 
saturation towards 10-4 M substrate. Similar kinetic behavior was observed across several 
enzyme/graphene samples and a range of DCPIP concentrations (from 10 M to 100 M) (Figure 
S14 (a)-(c)).  Across about 15 experiments, the catalytic current was seen to increase over this E1 
substrate concentration range by between 50% and 150% relative to the base-line DCPIP current. 
Each E1-E2-graphene electrode was subjected to measurements over a period of several hours (up 
to 8 hours) at room temperature, retaining activity for this period. Control experiments (see SI, 
Figure S18) confirmed the absence of increased catalysis at the E2-graphene platform in the 
presence of DCPIP and E1 substrate, but, critically, without E1. No increase in activity was 
detected also when adding E1 substrate to the system containing bare, unfunctionalized graphene 
(i.e. without both E1 and E2) and DCPIP. These all confirmed that increased activity after E1 
substrate addition occurs only when E1 adsorbs onto the E2-graphene platform.  
 
The E1-derived origin of the additional current was confirmed by chronoamperometry 
(conducted in a droplet configuration, see Experimental; raw data in SI, Figure S16), in which 
current change with time is tracked as a function of increasing E1 substrate concentration at fixed 
potential (here, 0.25 V applied to graphene vs. silver reference electrode). Amperometry-derived 
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enzyme kinetics match closely CV-derived kinetics (Figure 4(e)). Overall, the kinetics could be 
fitted with a relationship of the I = A/(1+(B/[S])n) type, yielding a sub-linear value of  n = 0.31 
0.05 and B = 1.45 (0.72) × 10-8 M for the chronoamperometric data, and n = 0.3 0.016 and 
B = 7.45 (1.3) × 10-8 M for the (CV)-derived data, indicating non-Michaelis-Menten dependence 
for E1 activity. The kinetics approach Michaelis-Menten behavior at the higher E1 substrate 
concentrations (roughly 10-5 M and above), but deviate from Michaelis-Menten behavior at the 
lower end of the E1 substrate concentration range (SI, Figure S17 and Table S1). Further 
experiments will be needed to determine the cause of the deviation from Michaelis-Menten 
behavior. 
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Figure 4. E2 complexes assemble on graphene to form a bio-platform on which target molecules 
can bind with retention of activity. E2-graphene is shown binding E1, E2’s natural protein partner, 
by AFM and FET transconductance measurements. Cyclic voltammetry (CV) and 
chronoamperometry are used to demonstrate E1 activity after binding to E2-graphene. (a) “Before” 
and “after” AFM (tapping mode in air) of same region: E2-graphene (panel 1), and E1-E2-
graphene (panel 2) after 10 minutes incubation of E2-graphene with 0.33 mg/ml E1 solution. Scale 
bars: 200 nm. Panel 3: height distributions before (black) and after (red) E1 early stage incubation, 
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as determined from the images in panels 1 and 2, respectively. (b) E1 attachment to E2-graphene 
is demonstrated via changes of FET transconductance against electrochemical gate voltage after 
E2-graphene incubation with E1 solutions of different concentrations (see Experimental Section, 
SI). (c) Enzymatic and electrochemical reaction schematics. (d) Cyclic voltammogram (scan rate 
0.03 V s-1) recorded after E1 immobilization on E2-graphene electrodes, in buffer only (olive), 
after adding 10 M DCPIP (red), and after additions of 3-methyl-2-oxopentanoate of final 
concentrations 50 nM (turquoise) and 4 mM (black). A full set of CV curves is shown in SI, Figure 
S14 (a). (e) Enzyme kinetics derived from both chronoamperometry and CV from data obtained 
at 100 M DCPIP (voltammograms shown in Figure S14 (c)). At each substrate concentration, the 
chronoamperometric current plateau value (Figure S16) was used.  
 
There was no E1 activity on bare graphene electrodes, with and without mediator, demonstrating 
that E1 adsorbed directly onto graphene does not retain detectable activity. Importantly, there was 
no E1 activity when E1 was incubated on bovine serum albumin (BSA)-graphene electrodes (SI, 
Figure S19), showing either that E1 does not bind to BSA-graphene or that it binds non-
productively; hence a non-specific (generic) protein spacer between E1 and graphene does not 
result in detectable E1 activity, highlighting the essential role of E2 in mediating biorecognition. 
It is reasonable to assume that E1-E2 interaction occurs via the physiological binding site, E2 
PSBD (Figure 1). Preservation of E1 activity on E2-graphene platforms is an important result as 
binding to surfaces, especially hydrophobic surfaces such as bare graphene, often impairs protein 
function; in previous examples, the relatively robust protein concanavalin A23 underwent almost 
complete loss of function upon adsorption onto graphene, and horseradish peroxidase64 lost about 
75% of its activity upon interaction with a graphenic material. As noted at the end of section 2.2, 
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however, IgG retains structure and function upon adsorption onto graphene,60 and BSA is predicted 
by simulation also to retain its structure upon adsorption onto graphene.61 Hence proteins display 
varying behavior upon direct interaction with graphene. Our results suggest that E2 complexes 
function as large footprint bridges that promote protein-surface interaction with retention of 
function. This is similar to the improvement brought about by tripodal linkers with large 
footprints24 compared to monopodal ones, but with the advantages described above and shown 
further below of specificity and enhanced functionality and versatility.  
 
The E1-E2-graphene system exhibits a very low detection limit, below 10-8 M substrate 
concentration, and a wide dynamic range spanning six orders of magnitude of substrate 
concentration. This is amongst the lowest detection limits encountered in biosensing with carbon-
based systems.15,17 E2-graphene performance contrasts strongly with E2-glassy carbon, where 
virtually no E1 activity was detected (data not shown). This highlights the key role played by 
graphene in allowing immobilized E2 complexes to retain substantial structural integrity and, 
consequently, specific binding capability. This behavior is rooted not only in the E2-graphene 
interactions (in which van der Waals forces and  stacking could be prominent, as discussed in 
section 2.2), but it potentially reflects also the relationship with the microstructure of the material: 
graphene has a flat, sp2-bonded surface, promoting a more ordered E2 monolayer coverage, while 
glassy carbon contains randomly oriented graphitic interwoven ribbons, with fullerene-like 
structure (i.e. containing buckled sheets with both sp2 and sp3 content) that could result in distortion 
of the E2 complexes. Furthermore, E1-E2-graphene shows a short response time, of about three 
seconds (SI, Figure S16) - an important characteristic for real time, in vivo detection.  
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E2 is not an electron transfer protein and therefore the E2 complex is a poor electron conductor. 
In general, the need for a mediator could be eliminated by engineering prosthetic groups such as 
haem and iron-sulfur clusters into the interior of the E2 complex to form an efficient electron 
transfer pathway across the complex. This should be feasible since haem C and iron-sulfur clusters, 
for example, can be coordinated by cysteine residues of proteins, and non-native cysteines have 
previously been incorporated into the E2 complex interior to allow E2 conjugation with 
maleimide-bearing compounds.43 In this scenario, E2 complexes with both interior and exterior 
modifications would be assembled on graphene. 
 
2.4. Towards a multifunctional bio-platform  
Finally, we produced a platform that incorporates different variants of E2. Modifications to E2 
can create new functionalities, for example by reversible denaturation and reassembly of mixed 
E2 monomers44 or incorporation of non-native cysteines for conjugation to the interior43 or exterior 
of the E2 complex.45 Alternatively, sortase A-mediated modification has been used for decoration 
of E2 complexes with multiple different molecules including one or more of antibody, enzyme, 
DNA aptamer and dye.38,39 Here, we labeled E2 monomers with fluorescein isothiocyanate (FITC) 
or a Ni-NTA-Atto red dye. FITC reacts with primary amines (–NH3+) found at polypeptide chain 
N-termini and in lysine side-chains. Ni-NTA-Atto red affinity labels the target protein via metal 
chelation by an N-terminal hexahistidine tag (we incorporated such a tag in E2 monomers for 
purification rather than recognition/labelling purposes).  
 
To illustrate the potential for E2 to be employed in multiplexed scenarios, micro-stamping was 
used as a convenient procedure to realize spatially separate regions of the two E2 variants (FITC- 
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and Ni-NTA-Atto-labelled) on graphene, allowing visualization by confocal laser scanning 
microscopy (Figure 5). E2 complex transfer was achieved without chemical linkers such as have 
been used previously for protein micro-patterning on graphene.65 FITC and Ni-NTA-Atto have 
emission fluorescence peaks at 520 and 576 nm, respectively, and their fluorescence was not 
quenched by the electronically gapless graphene. With typical biomolecule-based spacers between 
the fluorophore and graphene, fluorescence quenching is due to non-radiative decay; this decreases 
significantly for sizeable spacer thicknesses,66 as provided by E2 complexes which prevent FITC 
or Ni-NTA-Atto direct contact with graphene and which permit multiple FITC or Ni-NTA-Atto 
copies per complex. Ni-NTA-Atto-modified E2 complexes were stamped first and visualized at 
488 nm excitation with a LP560 filter, which allowed collection of emitted light above 560 nm 
(Figure 5(a)). FITC-labelled E2 lines were stamped next, above the Ni-NTA-Atto-E2 lines but at 
a different angle. FITC-E2 was then visualized at 488 nm excitation with a BP505-530 emission 
filter, which allowed collection of emitted light between 505 and 530 nm (Figure 5(b). The whole 
pattern was revealed using a combination of red and green filters (Figure 5(c)), while AFM images 
show that the CVD graphene is present around the patterned E2 lines.  
 
Better protein locational control and potentially decreased destruction risk for the underlying 
graphene may be achieved by more complex methods for E2 transfer than micro-stamping, such 
as E2 complex specific binding on appropriately functionalized graphene.  In future work, we will 
evaluate the comparative advantages, in complexity and performance, of both strategies. 
Nevertheless, this first example of transfer of different variants of E2 complexes on graphene is 
an initial step towards creation of multiplexed, multi-functional devices. Surfaces in such devices 
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could have multiplexed chemical/biochemical micro-patterns where E2 complexes with different 
functionalities are controllably transferred to build multiple functionalities on one platform.67  
 
 
Figure 5. Multiplexing different types of E2 complexes on CVD graphene. (a) Ni-NTA-Atto-
modified E2 complexes visualized at 488 nm excitation with a LP560 filter, which allowed 
collection of emitted light above 560 nm. (b) Lines of FITC-labelled E2 complexes visualized at 
488 nm excitation with a BP505-530 emission filter, which allowed collection of emitted light 
between 505 and 530 nm. (c) The whole pattern was revealed using a combination of red and green 
filters. (d) AFM images (panels 1 and 2) and topographic profile (panel 3) showing the stamped 
patterns of E2 complexes on top of, and surrounded by, CVD graphene (easily identifiable by the 
presence of characteristic domain boundaries within the graphene film). Panel 1 corresponds to 
the framed area from image (b), while a zoom in this line pattern area (panel 2) shows globular 
units compatible in lateral dimension with E2 complexes.  
 
3. Conclusion 
We have introduced a new bio-platform that combines versatile, self-assembling E2 protein 
complexes with graphene. E2 complexes are robust and their customizability means that the E2-
graphene platform can be adapted to multiple applications. Monolayer graphene (conveniently 
obtained in large areas and on a variety of substrates by CVD methods) provides a surface that is 
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sufficiently uniform and chemically simple to allow E2 complexes to directly self-assemble on it 
while retaining a supramolecular structure and ability to bind specifically to other enzymes without 
loss of enzyme function (here, tested with E1, E2’s physiological partner). These capabilities are 
not replicated when E2 complexes are used with standard electrochemical electrodes such as glassy 
carbon, highlighting the advantages of graphene when interfacing these supramolecular complexes 
with the solid state. This is the first use of E2 for solid state sensing: we have shown that E2-
graphene can detect E1 activity at substrate concentrations below 10-8 M, and that platforms can 
be made with defined patterns of different types of E2 complexes. Since the E2-graphene 
interaction is non-covalent, the graphene π–electron system is maintained and hence so are the 
numerous advantageous properties of graphene that derive from this electron system (including 
the capability of E2-graphene to be used in a field-effect transistor sensing configuration, which 
could be exploited in future iterations of this work). 
 
Moving beyond this proof-of-principle study, the E2-graphene bio-platform can be customized 
by modifying the E2 subunits.  Modified E2 complexes can be used for sensing,39 catalysis,38,39 
encapsulation,41,46 display/targeting/delivery,40,43,68,69 switching,46,47,70 imaging,47 synthesis,42 or a 
combination of one or more of these. The customization capacity of E2 and graphene means that 
the E2-graphene platform has considerable versatility and potential utility, for example for sensing 
a wide range of analytes, with the potential for greater functionality through multiplexing. The 
versatility of the E2-graphene platform increases further still when it is recognized that OADHCs 
are found in a huge range of organisms including aerobic bacteria and eukarya, providing a pool 
of E2 complexes encompassing a range of physico-chemical and biochemical characteristics such 
as number of component monomers, thermal stability, pH optimum, and charge distribution. We 
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will next interface graphene with further modified E2 complexes; interior modification to provide 
rapid electron transfer pathways (“internal wiring”) through the E2 complex will be combined with 
exterior decoration of E2 complexes, for example with anti-microbial peptides to create an E2-
graphene platform for sensing of bacterial pathogens.    
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4. Experimental Section 
Expression and purification of E1 and E2. Recombinant Thermoplasma acidophilum E2 and E1 
were purified via Ni2+-affinity chromatography, as described previously,37 dialysed into half 
strength phosphate buffered saline (PBS), pH 7.4 and stored at 4 °C until further use. Protein 
concentration was estimated by measuring absorbance at 280 nm in 6 M guanidine-HCl. E2 
complex assembly was induced by incubating E2 monomers at 55 °C for 10 min; assembly into 
complexes was confirmed by dynamic light scattering and analytical ultracentrifugation and cryo-
EM (SI). Prior to activity assays, E1 was incubated with its natural cofactor thiamine 
pyrophosphate (TPP, 0.2 mM) in the presence of 2 mM MgCl2 at 55 °C for 10 min to allow TPP 
binding to E1.  
E2 complex functionalization of graphene surfaces. All surfaces were incubated with E2 
complexes from 0.1 mg/ml stock solution (incubation times described in main text), then rinsed 
with PBS to remove excess E2 complexes, or with deionized water when performing AFM in air. 
Reproducibility of coverage was about  10%, based on partitioning height in ten different AFM 
images about a threshold value and then summing areas above and below that value. HOPG 
research grade with 0.8  0.2 mosaic spread (SPI), as opposed to a lower quality of graphite, 
gave good reproducibility and uniformity across the surface. For TEM, E2 complexes were 
incubated on graphene membranes, followed by negative staining with uranyl acetate for contour 
enhancement. 
AFM scanning conditions. Imaging of E2 complexes and measurement of apparent heights was 
performed in tapping mode in air on a MFP-3D Asylum microscope, with Si cantilevers (Olympus 
AC240TS, ~ 2 N/m spring constant, and ~ 73 kHz resonance frequency), in the regime of attractive 
average forces (phase > 90) and with the smallest oscillation amplitude attainable (~ 5 nm) to 
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minimize dynamic forces and increase sensitivity to short range forces (SI). High resolution 
imaging of E2 complex structure in air was obtained by decreasing the setpoint (i.e. the measured-
to-free amplitude ratio) until improved resolution was obtained in both topographic and phase 
images; or by working in liquid (on a Cypher microscope) with stiff, short cantilevers (BioLever 
Fast, 9 µm, 0.1 N/m, 1.5 MHz from Olympus) to ensure small oscillation amplitudes, and without 
protein fixation. See also SI.  
Electrochemical measurements of enzyme activity. Cyclic voltammetry (CV) was carried out in 
a purpose built three-electrode cell (volume ~4 cm3) containing glassy carbon counter, KCl-
saturated calomel reference (SCE, Radiometer, Copenhagen) and CVD graphene (~12 mm2) or 
glassy carbon (3 mm diameter) as working electrode. The reaction buffer contained PBS, pH 7.4, 
and 2 mM MgCl2, while concentrations of DCPIP spanning from 10 to 100 M were used across 
various experiments.  40 µl of EDTA was added to the reaction solution as a metal chelator, 
followed by 40 µl of MgCl2 to mop up any EDTA in the final solution. For electrochemistry 
experiments, E1 was incubated on E2-graphene from 0.33 mg/ml stock solution typically for 40 
minutes. Experiments on n  15 E1-E2-graphene samples resulted in very similar trends; five scans 
were taken at each substrate concentration, reproducibility being obtained usually after the second 
scan. The CV-derived E1 kinetics were obtained from the anodic current measured at 80 mV vs. 
SCE (after subtracting the DCPIP signal from it, and correcting for the slight increase of the non-
Faradaic contribution after sequential substrate additions). 
Chronoamperometry was performed in a droplet configuration: a silicone rubber reservoir (~50 
l) was formed around the graphene active area (~12 mm2), after which graphene was incubated 
with E2 and then E1, as for cyclic voltammetry. 20 l of the final solution, including DCPIP, 
covered E1-E2-graphene, and 1-2 l of substrate of increasing stock concentration was added to 
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the droplet. Silver (0.3 mm diameter) and platinum (0.3 mm diameter) wires, 2 mm distance apart 
and 1.5 mm immersion depth, were used as quasi-reference and auxiliary electrodes, respectively 
(see also SI, Figure S14). A potential of 0.25 V vs. Ag was applied, while the chronoamperometric 
current was measured after sequential additions of 2 l substrate to 20 l drop of PBS with 100 
M DCPIP as mediator (see SI, Figure S15). This current was used for determining the E1 kinetics 
shown in Figure 4(e), where the increase in droplet volume was considered when determining final 
substrate concentrations. Controls involving addition of just PBS to the droplet did not trigger an 
amperometric signal. Chronoamperometry in volumes as used for CV gave no measurable current 
without stirring, and a low signal-to-noise ratio with stirring.  
FET with liquid gate for detecting E1 attachment on E2-graphene. The transistor consisted of 
CVD monolayer graphene (~ 12 mm2) dry-transferred onto a SiO2(300nm)/Si substrate (see SI), 
with deposited metal contacts (10 nm Ti/ 50 nm Au), silicone rubber or solid PDMS defining a 
reservoir ( ~ 50 l) protecting the electrodes and leaving just graphene exposed to analyte; and a 
silver wire (0.3 mm diameter) as gate electrode in PBS (of various dilution factors). The source-
drain voltage was Vsd = 0.2 V for a length of channel of about 3 mm. E2 complexes (0.1 mg/ml 
solution) were first incubated for 10 minutes, the surface was washed with PBS, then 20 µl drops 
of increasing concentration (from 0.01 mg/ml to 1 mg/ml) of E1 in PBS were successively placed 
in the reservoir and incubated for 10 minutes. After each incubation, the graphene surface was 
rinsed with PBS to remove weakly attached proteins, and 40 µl of fresh diluted PBS (Debye length 
~ 3.5 nm) was then put as electrolyte in the reservoir to create the double layer required for 
transconductance measurements. Control experiments assessing effect of PBS, as well as E2 
attachment to graphene are described in SI. 
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Fluorescent labelling of E2. E2 complexe (1 mg/ml) was labelled using fluorescein 
isothiocyanate (FITC, 1 mg/ml in DMF, Sigma) or Ni-NTA-Atto 550 (Sigma) following the 
manufacturer's instructions. Samples were dialysed against half-strength PBS, pH 7.4 at 4 °C to 
remove any unbound fluorescent label. 
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